Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Living with Dementia

hormone therapy1 - baroness thatcher1 - entorhinal cortex1 - mentally weak1 - quality of care2 - hip fracture1 - agitation2 - behavioral signs1 - mri2 - als1 - apoplectic dementia1 - presbyophrenia1 - antioxidants1 - moderate parkinson's disease1 - senile atrophy and aphasia1 - dsm-51 - drug addiction1 - long-term cognitive changes1 - improved recognition1 - amentia2 - professor lewy1 - cell biology1 - dopamine-producing nerve cells1 - cognition function1 - early signs of dementia1 - diagnosis of ad1 - alzheimer's drug5 - preparing for appointment1 - alzheimer2 - alzheimer’s and dementia1 -